Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Study explores the negative consequences of social isolation

Never before have we experienced social isolation on a massive scale as we have during the evolving COVID-19 pandemic.

10 Jun 2020

Study sheds new light on memory impairment in Alzheimer's disease

Neurons that are responsible for new experiences interfere with the signals of neurons that contain memories and thereby disturb the recall of memories - at least in mice.

9 Jun 2020

Virginia Tech researcher develops new ‘fat burning’ molecule with potential to treat obesity

Obesity affects more than 40 percent of adults in the United States and 13 percent of the global population.

8 Jun 2020

Incidence of intracerebral hemorrhages increasing in older people, study finds

Brain bleeds called intracerebral hemorrhages remained stable in incidence among all age groups over the past 30 years, but they increased in people 75 and older, according to a new analysis of the Framingham Heart Study. The findings are in JAMA Neurology.

8 Jun 2020

Gene expression may be a decisive factor for controlling possible comorbidities

A study led by the Barcelona Supercomputing Center, in which the Universitat de València participates, concludes that the specific characteristics of each patient, such as gene expression, may be a decisive factor in the development of clinical strategies aimed at addressing and controlling possible comorbidities.

8 Jun 2020

Using antibodies to detect Alzheimer’s disease

News-Medical speaks to Professor Vendruscolo about his research that uses antibodies to detect Alzheimer's disease, which could help to improve drug discovery.

8 Jun 2020

Sleep fragmentation associated with inflammation and atherosclerosis

Disrupted nightly sleep and clogged arteries tend to sneak up on us as we age. And while both disorders may seem unrelated, a new study from the University of California, Berkeley, helps explain why they are, in fact, pathologically intertwined.

5 Jun 2020

Focusing on clinical drug research for dementia

Frontiers in Clinical Drug Research - Dementia is a book series which presents comprehensive reviews about research on Dementia, a term which references the loss of brain function associated with Alzheimer's disease and other related medical conditions.

5 Jun 2020

Education can protect older women against memory loss

Education appears to protect older adults, especially women, against memory loss, according to a study by investigators at Georgetown University Medical Center, published in the journal Aging, Neuropsychology, and Cognition.

5 Jun 2020

A roadmap to help older Britons struggling with 'shopping lists' of medication

New research provides a roadmap to help the millions of older Britons struggling with 'shopping lists' of medication, as fears grow that the current coronavirus lockdown could be further isolating the most vulnerable.

5 Jun 2020

Study reveals parts of the brain linked to facial and scene recognition

Using "sub-millimeter" brain implants, researchers at The University of Texas Health Science Center at Houston, have been able to determine which parts of the brain are linked to facial and scene recognition.

4 Jun 2020

Intranasal delivery of MSC-EVs shows promise for treating Alzheimer's disease

In the search for a cure for Alzheimer's disease, mesenchymal stem cells and their derived extracellular vesicles (MSC-EVs) offer much promise, thanks to their protective and anti-inflammatory properties.

4 Jun 2020

Effects of chronic stress associated with increased inflammatory signaling within brain circuits

Anxiety and depression are significantly heightened during times of great stress such as the COVID-19 pandemic.

4 Jun 2020

Antiepileptic drug use linked to higher risk of death among people with Alzheimer’s disease

The use of antiepileptic drugs is associated with a higher risk of death among persons with Alzheimer’s disease, according to a new study from the University of Eastern Finland.

4 Jun 2020

AFFiRiS announces preclinical results of monoclonal antibody mAB C6-17 in Huntington's

AFFiRiS, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies, today announced that detailed preclinical results with its monoclonal antibody mAB C6-17 to treat Huntington's Disease were published in the peer-reviewed journal Neurobiology of Disease.

3 Jun 2020